Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.
Leonard EK, Tomala J, Gould JR, Leff MI, Lin JX, Li P, Porter MJ, Johansen ER, Thompson L, Cao SD, Hou S, Henclova T, Huliciak M, Sargunas PR, Fabilane CS, Vaněk O, Kovar M, Schneider B, Raimondi G, Leonard WJ, Spangler JB.
Leonard EK, et al.
JCI Insight. 2024 Sep 24;9(18):e173469. doi: 10.1172/jci.insight.173469.
JCI Insight. 2024.
PMID: 39115939
Free PMC article.